cyanopindolol has been researched along with salmeterol xinafoate in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Charlton, SJ; Dickson, CJ; Duca, JS; Fairhurst, RA; Hornak, V; McKay, DJ; Pearlstein, RA; Reilly, J; Sandham, DA; Shaw, D; Sykes, DA; Velez-Vega, C | 1 |
| Green, SA; Liggett, SB; Rathz, DA; Schuster, AJ | 1 |
2 other study(ies) available for cyanopindolol and salmeterol xinafoate
| Article | Year |
|---|---|
Uncoupling the Structure-Activity Relationships of β2 Adrenergic Receptor Ligands from Membrane Binding.
Topics: Binding Sites; Cell Membrane; Dose-Response Relationship, Drug; Humans; Ligands; Models, Molecular; Molecular Structure; Receptors, Adrenergic, beta-2; Structure-Activity Relationship | 2016 |
The Ile164 beta(2)-adrenoceptor polymorphism alters salmeterol exosite binding and conventional agonist coupling to G(s).
Topics: Adrenergic beta-Agonists; Albuterol; Amino Acid Substitution; Animals; Binding Sites; Binding, Competitive; CHO Cells; Cricetinae; Dose-Response Relationship, Drug; Genotype; Humans; Iodine Radioisotopes; Isoproterenol; Metaproterenol; Pindolol; Polymorphism, Genetic; Radioligand Assay; Receptors, Adrenergic, beta-2; Salmeterol Xinafoate; Terbutaline | 2001 |